Home/ Stocks/ EQ

Equillium, Inc. Common Stock

EQ XNAS

$2.11 +0.09 (+4.23%) ▲ 15-min delayed

Open

$2.14

High

$2.17

Low

$2.08

Volume

406.6K

Market Cap

$134.04M

About Equillium, Inc. Common Stock

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 14 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-5,311,000	$-0.06
FY 2025	$0	$-22,398,000	$-0.39
Q3 2025	$0	$-4,230,000	$-0.06
Q2 2025	$0	$-5,739,000	$-0.16

Related Market News

No specific coverage for EQ yet. Check out our latest market news or earnings calendar.

Get EQ Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Equillium, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.